receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci. 2003; 24: 52-55.

References

Abbracchio MP, Ceruti S, Langfelder R, Cattabeni F, Saffrey MJ, Burnstock G. Effects of ATP analogues and basic fibroblast growth factor on astroglial cell differentiation in primary cultures of rat striatum. Int J Dev Neurosci 1995; 13: 685-693.

Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G. Characterization of the UDP-glucose receptor (re-named here the P2Y

receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci. 2003; 24: 52-55.

Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 2006;58:281-341.

Alvarado-Castillo C, Harden TK, Boyer JL. Regulation of P2Y

receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.

Mol Pharmacol 2005; 67:114-122.

Alvarado-Castillo C, Lozano-Zarain P, Mateo J, Harden TK, Boyer JL. A fusion protein of the human P2Y

receptor and NTPDase1 exhibits functional activities of the native receptor and ectoenzyme and reduced signaling responses to endogenously released nucleotides. Mol Pharmacol 2002; 62:521-528.

Andres-Barquin PJ, Hernandez MC, Israel MA. Id4 expression induces apoptosis in astrocytic cultures and is down-regulated by activation of the cAMP-dependent signal transduction pathway. Exp Cell Res. 1999; 247:347-55.

Arthur DB, Akassoglou K, Insel PA. P2Y

receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci USA 2005; 102:19138-19143.

Back M. Functional characteristics of cysteinyl-leukotriene receptor subtypes. Life Sci 2002; 71:

611-622.

Baldauf K, Reymann KG. Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia. Brain Res 2005; 1056:158-167.

Baldwin, JM. The probable arrangement of the helices in G protein-coupled receptors. EMBO J 1993; 12: 1693-1703.

Ballerini P, Di Iorio P, Ciccarelli R, Caciagli F, Poli A, Beraudi A, Buccella S, D’Alimonte I,

D’Auro M, Nargi E, Patricelli P, Visini D, Traversa U. P2Y

and cysteinyl leukotriene receptors

mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia. Int J

Immunopathol Pharmacol 2005; 18:255-268.

Beigi F, Wainer IW. Syntheses of immobilized G protein-coupled receptor chromatographic stationary phases: characterization of immobilized mu and kappa opioid receptors. Anal Chem 2003; 75: 4480-4485.

Beigi F, Chakir K, Xiao RP, Wainer IW. G-protein-coupled receptor chromatographic stationary phases: II. Ligand-induced conformational mobility in an immobilized β2- adrenergic receptor, Anal Chem 2004; 76:7187-7193.

Benned-Jensen T, Rosenkilde MM. Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants. Br J Pharmacol. 2010;159:1092-1105.

Bockaert J, Pin JP. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J, 1999; 18:1723-1729.

Bodor ET, Waldo GL, Hooks SB, Corbitt J, Boyer JL, Harden TK. Purification and functional reconstitution of the human P2Y

receptor. Mol Pharmacol 2003; 64, 1210-1216.

Boyce J. Eicosanoids in asthma, allergic inflammation, and host defense. Curr Mol Med 2008;

8:335-339.

Brash A. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999; 274: 23679-23682.

Buffo A, Rolando C, Ceruti S. Astrocytes in the damaged brain:Molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 2010; 79:77-89.

Burnstock G. Do some nerve cells release more than one transmitter? Neuroscience 1976;

1:239–248.

Burnstock G. A basis for distinguishing two types of purinergic receptor, in cell membrane receptors for drugs and hormones: a multidisciplinary approach (Straub, RW and Bolis L eds), 1978;107-118, Raven Press, New York.

Burnstock G, Warland JJ. P2-purinoceptors of two subtypes in the rabbit mesenteric artery:

Reactive blue 2 selectively inhibits responses mediated via the P2Y-but not the P2X- purinoceptor. Br J Pharmacol 1987; 90:383-391.

Burnstock G. The past, present and future of purine nucleotides as signalling molecules.

Neuropharmacology. 1997; 36(9):1127-1139.

Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004; 240:31-34.

Cai Y, Wu P, Ozen M, Yu Y, Wang J, Ittmann M, Liu M. Gene expression profilingand analysis of signaling pathways involved in priming and differentiation of human neural stem cells.

Neuroscience 2006;138:133-148.

Calleri E, Ceruti S, Cristalli G, Martini C, Temporini C, Parravicini C, Volpini R, Daniele S, Caccialanza G, Lecca D, Lambertucci C, Trincavelli ML, Marucci G, Wainer IW, Ranghino G, Fantucci P, Abbracchio MP, Massolini G. Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. J Med Chem. 2010; 53:3489- 3501.

Carlén M, Meletis K, Göritz C, Darsalia V, Evergren E, Tanigaki K, Amendola M, Barnabé- Heider F, Yeung MS, Naldini L, Honjo T, Kokaia Z, Shupliakov O, Cassidy RM, Lindvall O, Frisén J. Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat Neurosci. 2009; 12:259-267.

Capra V. Molecular and functional aspects of human cysteinyl leukotriene receptors.

Pharmacol Res 2004; 50:1-11.

Capra V, Ravasi S, Accomazzo MR, Citro S, Grimoldi M, Abbracchio MP, Rovati GE. CysLT

receptor is a target for extracellular nucleotideinduced heterologous desensitization: a possible feedback mechanism in inflammation. J Cell Sci 2005; 118:5625-5636.

Capra V, Ambrosio M, Riccioni G, Rovati GE. Cysteinyl-leukotriene receptor antagonists:

present situation and future opportunities. Curr Med Chem. 2006; 13:3213-3226.

Capra V, Thompson MD, Sala A, Cole DE, Folco G, Rovati GE. Cysteinyl-leukotrienes and their receptors in asthma and other infammatory diseases: critical update and emerging trends. Med Res Rev 2007; 27:469-527.

Ceruti S, Fumagalli M, Villa G, Verderio C, Abbracchio MP. Purinoceptor-mediated calcium signaling in primary neuron-glia trigeminal cultures. Cell Calcium. 2008; 43:576-590.

Ceruti S, Villa G, Genovese T, Mazzon E, Longhi R, Rosa P, Bramanti P, Cuzzocrea S, Abbracchio MP. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury. Brain. 2009; 132:2206-2218.

Ceruti S, Viganò F, Boda E, Ferrario S, Magni G, Boccazzi M, Rosa P, Buffo A, Abbracchio MP.

Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death. Glia. 2010, in press.

Chambers JK, Macdonald LE, Sarau HM, Ames RS. Freeman K, Foley, J. J Zhu Y, McLaughlin MM, Murdock P, McMillan L, Trill J, Swift A, Aiyar N, Taylor P, Vawter L, Naheed S, Szekeres P, Hervieu G, Scott C, Watson JM, Murphy AJ, Duzic E, Klein C, Bergsma DJ, Wilson S, Livi GP. A G protein-coupled receptor for UDP-glucose. J Biol Chem 2000; 275:10767-10771.

Chhatriwala M, Ravi RG, Patel RI, Boyer JL, Jacobson KA, Harden TK. Induction of novel agonist selectivity for the ADP-activated P2Y

receptor versus the ADP-activated P2Y

and P2Y

receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther 2004;

311:1038-1043.

Chao CC, Su LJ, Sun NK, Ju YT, Lih JC, Lin-Chao S. Involvement of Gas7 in nerve growth factor-independent and dependent cell processes in PC12 cells. J Neurosci Res. 2003; 74:248- 254.

Chen Y, Wu H, Wang S, Koito H, Li J, Ye F, Hoang J, Escobar SS, Gow A, Arnett HA, Trapp BD, Karandikar NJ, Hsieh J, Lu QR. The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat Neurosci. 2009;12:1398-1406.

Cheng X, Wang Y, He Q, Qiu M, Whittemore SR, Cao Q. Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells. 2007; 25:3204-3214.

Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, Ferrario S, Parravicini C, Capra V, Gelosa P, Guerrini U, Belcredito S, Cimino M, Sironi L, Tremoli E, Rovati GE, Martini C, Abbracchio MP. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J 2006; 25:4615-4627.

Colotta V, Catarzi D, Varano F, Lenzi O, Filacchioni G, Martini C, Trincavelli L, Ciampi O, Traini C, Pugliese AM, Pedata F, Morizzo E, Moro S. Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3- a]quinoxalin-1-one derivatives as potent and selective human A

adenosine receptor antagonists. Bioorg Med Chem 2008; 16:6086-6102.

Communi D, Pirotton S, Parmentier M, Boeynaems JM. Cloning and functional expression of a human uridine nucleotide receptor. J Biol Chem 1995; 270:30849-30852.

Communi D, Govaerts C, Parmentier M, Boeynaems JM. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 1997; 272:31969-31973.

Communi D, Gonzalez NS, Detheux M, Brézillon S, Lannoy V, Parmentier M, Boeynaems JM.

Identification of a novel human ADP receptor coupled to G(i). J Biol Chem 2001; 276:41479- 41485.

Currie GP, Lee DK, Haggart K, Bates CE, Lipworth BJ. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. Am J Respir Crit Care Med 2003;167:1232-1238.

D’Ambrosi N, Cavaliere F, Merlo D, Milazzo L, Mercanti D, Volonte C. Antagonists of P2 receptor prevent NGF dependent neuritogenesis in PC12 cells. Neuropharmacology 2000;

39:1083-1094.

D’Ambrosi N, Murra B, Cavaliere F, Amadio S, Bernardi G, Burnstock G, Volonte C.

Interaction between ATP andnerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells. Neuroscience 2001; 108:527-534.

D’Ambrosi N, Murra B, Vacca F, Volonte C. Pathways of survival induced by NGF and

extracellular ATP after growth factor deprivation. Prog Brain Res 2004; 146:93-100.

Daniele S, Lecca D, Trincavelli ML, Ciampi O, Abbracchio MP, Martini C. Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17. Cell Signal. 2010; 22:697- 706.

Das A, Ko H, Burianek LE, Barrett MO, Harden TK, Jacobson KA. Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups. J Med Chem 2010; 53:471-480.

De Biase LM, Nishiyama A, Bergles DE. Excitability and synaptic communication within the oligodendrocyte lineage. J Neurosci 2010; 30:3600-3611.

Ding Z, Tuluc F, Bandivadekar KR, Zhang L, Jin J, Kunapuli SP. Arg333 and Arg334 in the COOH terminus of the human P2Y

receptor are crucial for Gq coupling. Am J Physiol Cell Physiol 2005; 288:C559-C567.

Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004; 113:340-345.

Duchala CS, Asotra K, Macklin WB. Expression of cell surface markers and myelin proteins in cultured oligodendrocytes from neonatal brain of rat and mouse: A comparative study. Dev Neurosci 1995; 17:70-80.

Dunn PM, Blakeley AG. Suramin: A reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol 1988; 93:243-245.

Erb L, Garrad R, Wang Y, Quinn T, Turner JT, Weisman GA. Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity. J Biol Chem 1995; 270:4185-4188.

Ferguson SS, Caron MG. G protein coupled receptor adaptation mechanisms. Semin Cell Dev Biol 1998; 9:119-127.

Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001; 53, 1-24.

Figueroa DJ, Breyer RM, Defoe SK, Kargman S, Daugherty BL, Waldburger K, Liu Q, Clements M, Zeng Z, O'Neill GP, Jones TR, Lynch KR, Austin CP, Evans JF. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001; 163:226-233.

Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 2003;33:1380-1388.

Filippov AK, Brown DA, Barnard EA. The P2Y

receptor closes the N-type Ca2+ channel in

neurones, with both adenosine triphosphates and diphosphates as potent agonists. Br J

Pharmacol 2000; 129:1063-1066.

Fok-Seang J, Miller RH. Distribution and differentiation of A2B5þ glial precursors in the developing rat spinal cord. J Neurosci Res1994; 37:219-235.

Fredriksson R, Lagerström MC, Lundin LG, Schiöth HB: The G-proteincoupledreceptors in the hu man genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 2003; 63:1256-1272.

Fumagalli M, Brambilla R, D'Ambrosi N, Volonté C, Matteoli M, Verderio C, Abbracchio MP.

Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors. Glia 2003;43:218-203.

Fumagalli M, Trincavelli ML, Lecca D, Martini C, Ciana P, Abbracchio MP. Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. Biochem Pharmacol 2004; 68:113-124.

Fumagalli M, Daniele S, Lecca D, Lee PR, Parravicini C, Fields RD, Rosa P, Antonucci F, Verderio C, Trincavelli ML, Martini C, Abbracchio MP. Phenotypic changes and signaling pathway of GPR17-expressing neural precursor cells during oligodendrocyte differentiation. J Biol Chem 2011, in press.

Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheocromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 1976; 73:2424-2428.

Greene LA, Aletta JM, Rukenstein A, Green SH. PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation. Methods Enzymol 1987; 147:207-216.

Grimm I, Messemer N, Stanke M, Gachet C, Zimmermann H. Coordinate pathways for nucleotide and EGF signaling in cultured adult neural progenitor cells. J Cell Sci 2009;

122:2524-2533.

Gribkoff VK, Starrett JEJr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, Yeola SW. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 2001; 7:471-477.

Hagg T. Molecular regulation of adult CNS neurogenesis: An integrated view. Trends Neurosci 2005; 28:589-595.

Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EY, Velasquez J, Kuhn P,

Stevens RC. A specific cholesterol binding site is established by the 2.8 A structure of the

human beta2-adrenergic receptor. Structure 2008; 16:897-905.

Häussinger D, Stehle T, Gerok W. Actions of extracellular UTP and ATP in perfused rat liver:

a comparative study. Eur J Biochem 1987; 167:65-71.

Hechler B, Vigne P, Leon C, Breittmayer JP, Gachet C, Frelin C. ATP derivatives are antagonists of the P2Y1-receptor: similarities to the platelet ADP receptor. Mol Pharmacol 1998; 53:727-733.

Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, Jr Williams DL, Zeng Z, Liu Q, Ma L, Clements MK, Coulombe N, Liu Y, Austin CP, George SR, O'Neill GP, Metters KM, Lynch KR, Evans JF. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000; 275:30531-30536.

Hoffmann C, Moro S, Nicholas RA, Harden TK, Jacobson KA. The role of amino acids in extracellular loops of the human P2Y

receptor in surface expression and activation processes.

J Biol Chem 1999; 274:14639-14647.

Howard AD, McAllister G, Feighner SD, Liu Q, Nargund RP, Van der Ploeg, LH, Patchett AA.

Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol Sci 2001; 22: 132-140.

Hu H, Chen G, Zhang J, Zhang W, Zhang L, Ge Q, Yao H, Ding W, Chen Z, Wei E.

Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors. Acta Pharmacol Sin 2005; 26: 685-690.

Hui Y, Yang G, Galczenski H, Figueroa DJ, Austin CP, Copeland NG, Gilbert DJ, Jenkins NA, Funk CD. The Murine Cysteinyl Leukotriene 2 (CysLT 2 ) Receptor. J Biol Chem 2001;

276:47489-47495.

Im DS. New intercellular lipid mediators and their GPCRs: an update. Prostaglandins Other Lipid Mediat 2009; 89:53-56.

Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD. Astrocytes promote myelination in response to electrical impulses. Neuron. 2006; 49:823-832.

Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP, Stevens RC. The 2.6 angstrom crystal structure of a human A

adenosine receptor bound to an antagonist. Science 2008; 322:1211-1217.

Jacobson KA, Boeynaem JM. P2Y nucleotide receptors: promise of therapeutic applications.

Drug Discov Today, 2010; 15:370-378.

Jalink K, Moolenaar WH. G protein-coupled receptors: the inside story. BioEssays 2010; 32:13- 16.

Jennemann R, Sandhoff R, Wang S, Kiss E, Gretz N, Zuliani C, Martin-Villalba A, Jäger R,

Schorle H, Kenzelmann M, Bonrouhi M, Wiegandt H, Gröne HJ. Cell-specific deletion of

glucosylceramide synthase in brain leads to severe neural defects after birth. Proc Natl Acad Sci USA 2005; 102:12459-12464.

Jiang Q, Guo D, Lee BX, Van Rhee AM, Kim YC, Nicholas RA, Schachter JB, Harden TK, Jacobson KA. A mutational analysis of residues essential for ligand recognition at the human P2Y

receptor. Mol Pharmacol 1997; 52:499-507.

Jiang Y, Borrelli LA, Kanaoka Y, Bacskai BJ, Boyce JA. CysLT2 receptors interact with CysLT

receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood 2007; 110:3263–-3270.

Joubert L, Foucault I, Sagot Y, Bernasconi L, Duval F, Alliod C, Frossard MJ, Pescini Gobert R, Curchod ML, Salvat C, Nichols A, Pouly S, Rommel C, Roach A, Hooft van Huijsduijnen R.

Chemical inducers and transcriptional markers of oligodendrocyte differentiation. J Neurosci Res. 2010; 88:2546-2557.

Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000; 10:381-391.

Karlsson M, Mandl M, Keyse SM. Spatio-temporal regulation of mitogen-activated protein kinase (MAPK) signalling by protein phosphatases. Biochem Soc Trans. 2006; 34:842-845.

Katritch V, Jaakola VP, Lane JR, Lin J, Ijzerman AP, Yeager M, Kufareva I, Stevens RC, Abagyan R. Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists. J Med Chem 2010; 53:1799-1809.

Kim Y, Seger R, Suresh Babu CV, Hwang SY, Yoo YS. A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation. Mol Cells 2004; 18:353-359.

King BF, Townsend-Nicholson A, Burnstock G. Metabotropic receptors for ATP and UTP:

Exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol Sci 1998; 9:506-514.

Kolakowski JrLF. GCRDb: a G-protein-coupled receptor database. Receptors Channels 2004;

2:1–7.

Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G proteincoupled receptor regulation. Annu Rev Pharmacol Toxicol 1998; 38:289-319.

Kubista H, Lechner SG, Wolf AM, Boehm S. Attenuation of the P2Y receptor-mediated control of neuronal Ca

channels in PC12 cells by antithrombotic drugs. Br J Pharmacol 2003; 138:343- 350.

Kügelgen IV. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.

Pharmacol Ther 2006; 110:415-432.

Labat C, Ortiz J, Norel X, Gorenne I, Verley J, Abram T, Cuthbert N, Tudhope S, Norman P, Gardiner P, Brink C. A second cysteinyl leukotriene receptor in human lung. J Pharmacol Exp Ther 1992; 263: 800-805.

Lambrecht G. Design and pharmacology of selective P2-purinoceptor antagonists. J Auton Pharmaco 1996; 16:314-344.

Lambrecht G. Agonists and antagonists acting at P2X receptors: Selectivity profiles and functional implications. Naunyn-Schmiedeberg’s Arch Pharmacol 2000; 362:340-350.

Lecca D, Ceruti S. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation. Biochem Pharmacol. 2008;75:1869-1881.

Lecca D, Trincavelli ML, Gelosa P, Sironi L, Ciana P, Fumagalli M, Villa G, Verderio C, Grumelli C, Guerrini U, Tremoli E, Rosa P, Cuboni S, Martini C, Buffo A, Cimino M, Abbracchio MP. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS One. 2008; 3:e3579-3794.

Leipziger J. Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol 2003; 284:F419-F432.

Leon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C. The P2Y

receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 1997; 403:26-30.

Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte lineage connection.

Cell 2002; 109:75-86.

Lustig KD, Shiau AK, Brake AJ, Julius D. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci USA 1993; 90:5113-5117.

Lynch K, Gary P, O’Neill G, Liu Q, Im DS, Sawyer N, Metters K, Coulombe N, Abramovitz M, Figueroa D, Zeng Z, Connolly B, Bai C, Austin C, Chateauneuf A, Stocco R, Greig G, Kargman S, Hooks S, Hosfield E, Williams DJ, Ford-Hutchinson A, Caskey C, Evans J. Characterization of the human cysteinyl leukotriene CysLT 1 receptor. Nature 1999; 399:789-793.

Maclouf J, Murphy R, Henson P. Transcellular sulfidopeptide leukotriene biosynthetic capacity of vascular cells. Blood 1989; 74:703-707.

Maclouf J, Sala A, Rossoni G, Berti F, Muller-Peddinghaus R, Folco G. Consequences of transcellular biosynthesis of leukotriene C4 on organ function. Haemostasis 1996; 26: 28-36.

Maekawa A, Balestrieri B, Austen KF, Kanaoka Y. GPR17 is a negative regulator of the

cysteinyl leukotriene 1 receptor response to leukotriene D

. Proc Natl Acad Sci USA

2009;106:11685-11690.

Maekawa A, Xing W, Austen KF, Kanaoka Y. GPR17 regulates immune pulmonary inflammation induced by house dust mites. J Immunol 2010; 185:1846-1854.

Maisel M, Herr A, Milosevic J, Hermann A, Habisch HJ, Schwarz S, Kirsch M, Antoniadis G, Brenner R, Hallmeyer-Elgner S, Lerche H, Schwarz J, Storch A. Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state. Stem Cells. 2007; 25:1231-1240.

Mamedova L, Capra V, Accomazzo MR, Gao Z, Ferrario S, Fumagalli M, Abbracchio MP, Rovati GE, Jacobson KA. CysLT

leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. Biochem Pharmacol 2005; 71:115-125.

Mark MD, Liu Y, Wong ST, Hinds TR, Storm DR. Stimulation of neurite outgrowth in PC12 cells by EGF and KCl depolarization: a Ca(2+)-independent phenomenon. J Cell Biol 1995;

130:701-710.

Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995 ;80:179-185.

Marteau F, Le Poul E, Communi D, Labouret C, Savi P, Boeynaems JM, Gonzalez NS Pharmacological characterization of the human P2Y

receptor. Mol Pharmacol 2003; 64:104- 112.

McGraw DW, Mihlbachler KA, Schwarb MR, Rahman FF, Small KM, Almoosa KF, Liggett SB.

Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complex. J Clin Invest 2006; 116:1400-1409.

Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M, Pedata F. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int 2005;

47:442-448.

Meletis K, Barnabé-Heider F, Carlén M, Evergren E, Tomilin N, Shupliakov O, Frisén J. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol. 2008; 6:e182- 190.

Michel AD, Grahames CBA, Humphrey PPA. Functional characterization of P2 purinoceptors in PC12 cells by measurement of radiolabelled calcium influx. Naunyn-Schmiedeberg’s Archives of Pharmacology 1996; 354:562-571.

Milligan G. Principles: extending the utility of [

S]GTP gamma S binding assays. Trends Pharmacol Sci 2003; 24:87-90.

Moaddel R, Calleri E, Massolini G, Frazier CR, Wainer IW. The synthesis and initial

characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography

stationary phase for online screening. Anal Biochem 2007; 364:216-218.

Moaddel R, Lu L, Baynham M, Wainer IW. Immobilized receptor- and transporter-based liquid chromatographic phases for on-line pharmacological and biochemical studies: a mini- review. J Chromatogr B 2002; 768:41-53.

Mori K, Miyazato M, Ida T, Murakami N, Serino R, Ueta Y, Kojima M, Kangawa K.

Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J. 2005; 24:325-335.

Moro S, Guo D, Camaioni E, Boyer JL, Harden TK, Jacobson KA. Human P2Y

receptor:

molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem 1998, 41:1456-1466.

Moro S, Hoffmann C, Jacobson KA. Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y

receptor.

Biochemistry 1999, 38:3498-3507.

Morooka T, Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem 1998; 273:24285-24288.

Muccitelli RM, Tucker SS, Hay DW, Torphy TJ, Wasserman MA. Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine- and antigen-induced contractions. J Pharmacol Exp Ther 1987;

243:467-473.

Nave, K.A. Neurological mouse mutants and the genes of myelin. J Neurosci Res 1994; 38:607- 612.

Neary JT, Rathbone M.P, Cattabeni F, Abbracchio MP, Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 1996;

19:13-18.

Neary JT, Zimmermann H. Trophic functions of nucleotides in the central nervous system.

Trends Neurosci 2009; 32: 189-198.

Neer E. Heterotrimeric C proteins: organizers of transmembrane signals.Cell 1995; 80:249-257.

Nery S, Wichterle H, Fishell G. Sonic hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. Development 2001; 128:527-540.

Nishiyama A, Komitova M, Suzuki R, Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci. 2009; 10:9-22.

Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. 1988. Platelet-derived growth

factor promotes division and motility and inhibits premature differentiation of the

oligodendrocyte/type-2 astrocyte progenitor cell. Nature 1988; 333:560-562.

Nonaka Y, Hiramoto T, Fujita N. Identification of endogenous surrogate ligands for human P2Y

receptors by in silico and in vitro methods. Biochem Biophys Res Commun 2005;

337:281-288.

Nothacker HP, Wang Z, Zhu Y, Reinscheid RK, Lin SH, Civelli O. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. Mol Pharmacol 2000; 58:1601-1608.

O’Connor SE, Dainty IA, Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci 1991; 12:137-141.

Otero M, Garrad RC, Velazquez B, Hernández-Pérez MG, Camden JM, Erb L, Clarke LL, Turner JT, Weisman GA, González FA. Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y

nucleotide receptor. Mol Cell Biochem 2000; 205:115- 123.

Parameswaran K, Liang H, Fanat A, Watson R, Snider DP, O'Byrne PM. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J Allergy Clin Immunol 2004; 114:73-79.

Parravicini C, Ranghino G, Abbracchio MP, Fantucci P. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors. BMC Bioinformatics. 2008; 9:263-282.

Parravicini C, Abbracchio MP, Fantucci P, Ranghino G. Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach. BMC Struct Biol. 2010; 10:8-26.

Pellegrino MJ, Stork PJ. Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells. Journal of Neurochem 2006; 99, 1480-1493.

Pidgeon C, Marcus C, Alvarez F in: Baldwin TO, Kelly JW (Eds.). Applications of Enzyme Biotechnology, Plenum, New York, 1992; 201-237.

Pitcher J, Lohse MJ, Codina J, Caron MG, Lefkowitz R.J. Desensitization of the isolated b2- adrenergic receptor by b-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. Biochemistry 1992; 31, 3193-3197.

Pooler AM, Guez DH, Benedictus R, Wurtman RJ. Uridine enhances neurite outgrowth in nerve growth factordifferentiated PC12. Neuroscience 2005; 134:207-214.

Pringle NP, Mudhar HS, Collarini EJ, Richardson WD. PDGF receptors in the rat CNS: During

late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the

oligodendrocyte lineage Development 1992; 115:535-551.

Pringle NP, Richardson WD. A singularity of PDGF alpha-receptor expression in the dorsoventral axis of the neural tube may defin the origin of the oligodendrocyte lineage.

Development 1993; 117: 525-533.

Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC. Sequence alignment of the G- protein coupled receptor superfamily. DNA Cell Biol 1992; 11: 1-20.

Pugliese AM, Trincavelli ML, Lecca D, Coppi E, Fumagalli M, Ferrario S, Failli P, Daniele S, Martini C, Pedata F, Abbracchio MP. Functional characterization of two isoforms of the P2Y- like receptor GPR17: [

S]GTPgammaS binding and electrophysiological studies in 1321N1 cells. Am J Physiol Cell Physiol. 2009; 297:C1028-1040.

Qu Z, Wolfraim LA, Svaren J, Ehrengruber MU, Davidson N, Milbrandt J. The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells. J Cell Biol. 1998;

142:1075-1082.

Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50:413–

492.

Ralevic V, Burnstock G. Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 2003; 16:133-140.

Ravni A, Vaudry D, Gerdin MJ, Eiden MV, Falluel-Morel A, Gonzalez BJ, Vaudry H, Eiden LE.

A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells. Mol Pharmacol. 2008; 73:1688-1708.

Rinaldo-Matthis A, Haeggstrom JZ. Structures and mechanisms of enzymes in the leukotriene cascade. Biochimie 2010; 92:676-681.

Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, Kessaris N, Richardson WD.

PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat Neurosci 2008; 11:1392-1401.

Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007; 318:1266-1273.

Sarau H, Ames R, Chambers J, Ellis C, Elshourbagy N, Foley J, Schmidt D, Muccitelli R, Jenkins O, Murdock P, Herrity N, Halsey W, Sathe G, Muir A, Nuthulaganti P, Dytko G, Buckley P, Wilson S, Bergsma D, Hay D: Identification, molecular cloning, expression and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 1999; 56:657-663.

Sesma JI, Esther CRJr, Kreda SM, Jones L, O'Neal W, Nishihara S, Nicholas RA, Lazarowski

ER. Endoplasmic reticulum/Golgi nucleotide sugar transporters contribute to the cellular

release of UDP-sugar signaling molecules. J Biol Chem 2009; 284:12572-12583.

Sheng WW, Li CT, Zhang WP, Yuan YM, Hu H, Fang SH, Zhang L, Wei EQ. Distinct roles of CysLT1 and CysLT2 receptors in oxygen glucose deprivation-induced PC12 cell death Biochem Biophys Res Commun. 2006; 346:19-25.

Spinozzi F, Russano AM, Piattoni S, Agea E, Bistoni O, de Benedictis D, de Benedictis FM.

Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes. Clin Exp Allergy 2004; 34:1876-1882.

Srinivasan S, Mir F, Huang JS, Khasawneh FT, Lam SC, Le Breton GC. The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels. J Biol Chem 2009; 284:16108-16117.

Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions.

Prog Neurobiol 1998; 56: 149-171.

Stork PJ. Directing NGF's actions: it's a Rap. Nat Cell Biol 2005 ;7:338-339.

Stevens B, Porta S, Haak LL, Gallo V, Fields RD. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 2002; 36:855-868.

Sun T, Pringle NP, Hardy AP, Richardson WD, Smith HK. Pax6 influences the time and site of origin of glial precursors in the ventral neural tube. Mol Cell Neurosci 1998; 12:228-239.

Surprenant A, North RA. Signaling at purinergic P2X receptors. Annu Rev Physiol. 2009;

71:333-359.

Takasaki J, Kamohara M, Matsumoto M, Saito T, Sugimoto T, Ohishi T, Ishii H, Ota T, Nishikawa T, Kawai Y, Masuho Y, Isogai T, Suzuki Y, Sugano S, Furuichi K. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor.

Biochem Biophys Res Commun 2000; 274:316-322.

Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y. The basic helix-loop-helix factor Olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol 2002; 12:1157-1163.

Temporini C, Ceruti S, Calleri E, Ferrario S, Moaddel R, Abbracchio MP, Massolini G.

Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry. Anal Biochem. 2009;

384:123-129.

Trincavelli ML, Tonazzini I, Montali M, Abbracchio MP, Martini C. Short-term TNF-Alpha treatment induced A

adenosine receptor desensitization in human astroglial cells. J Cell Biochem 2008; 104:150-161.

Van Rhee AM, Fischer B, Van Galen PJ, Jacobson KA: Modelling the P2Y purinoceptor using

rhodopsin as template. Drug Des Discov 1995, 13:133-154.

Verkhratsky A, Krishtal OA, Burnstock G. Purinoceptors on neuroglia. Mol Neurobiol 2009;

39:190-208.

von Kügelgen I, Häussinger D, Starke K. Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn-Schmiedeberg’s Arch Pharmacol 1987; 336:556-560.

von Kügelgen I, Schöffel E, Starke K. Inhibition by nucleotides acting at presynaptic P2- receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens.

Naunyn-Schmiedebergs Arch Pharmacol 1989; 340:522-532.

Waldo GL, Harden TK. Agonist binding and Gq-stimulating activities of the purified human P2Y

receptor. Mol Pharmacol 2004; 65:426-436.

Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008; 454:486-491.

White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 1998; 396:679-682.

White PJ, Webb TE, and Boarder MR. Characterization of a Ca

response to both UTP and ATP at human P2Y

receptors: evidence for agonist-specific signaling. Mol Pharmacol 2003;

63:1356-1363.

Williams A,Piaton G,Lubetzki C.Astrocytes-Friends or foes in multiple sclerosis? Glia 2007;

55:1300-1312.

Winkler JD, Sarau HM, Foley JJ, Crooke ST. Leukotriene D4-induced homologous desensitization in basal and differentiated U-937 cells: characterization with the partial agonist leukotriene E

and assessment of receptor reserve. J Pharmacol Exp Ther 1988; 247:54-62.

Zhou Q, Anderson DJ. The bHLH transcription factors Olig2 and Olig1 couple neuronal and

glial subtype specification. Cell 2002; 109:61-73.